Skip to main content

Peer Review reports

From: The safety, tolerability, pharmacokinetics, and pharmacodynamics of nebulized pegylated interferon α-2b in healthy adults: a randomized phase 1 trial

Original Submission
6 Aug 2024 Submitted Original manuscript
7 Oct 2024 Reviewed Reviewer Report
16 Jan 2025 Reviewed Reviewer Report
1 Feb 2025 Reviewed Reviewer Report
15 Feb 2025 Author responded Author comments - Qing Zhou
19 Feb 2025 Author responded Author comments - Qing Zhou
Resubmission - Version 2
15 Feb 2025 Submitted Manuscript version 2
12 Apr 2025 Reviewed Reviewer Report
12 Apr 2025 Reviewed Reviewer Report
27 Apr 2025 Author responded Author comments - Qing Zhou
Resubmission - Version 3
27 Apr 2025 Submitted Manuscript version 3
Publishing
29 Apr 2025 Editorially accepted
12 May 2025 Article published 10.1186/s40360-025-00937-9

You can find further information about peer review here.

Back to article page